Tunable control of CAR T cell activity through tetracycline mediated disruption of protein–protein interaction
Abstract Chimeric antigen receptor (CAR) T cells are a promising form of cancer immunotherapy, although they are often associated with severe toxicities. Here, we present a split-CAR design incorporating separate antigen recognition and intracellular signaling domains. These exploit the binding betw...
Guardado en:
Autores principales: | Alastair Hotblack, Evangelia K. Kokalaki, Morgan J. Palton, Gordon Weng-Kit Cheung, Iwan P. Williams, Somayya Manzoor, Thomas I. Grothier, Alice Piapi, Valeria Fiaccadori, Patrycja Wawrzyniecka, Harriet A. Roddy, Giulia Agliardi, Claire Roddie, Shimobi Onuoha, Simon Thomas, Shaun Cordoba, Martin Pule |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dee4a8da64cb4a34bd085ebded529484 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Honeybees and Tetracycline Resistance
por: Stuart B. Levy, et al.
Publicado: (2013) -
On-Chip Purification of Tetracyclines Based on Copper Ions Interaction
por: Lorenzo Lunelli, et al.
Publicado: (2021) -
Maximum levels of cross‐contamination for 24 antimicrobial active substances in non‐target feed. Part 12: Tetracyclines: tetracycline, chlortetracycline, oxytetracycline, and doxycycline
por: EFSA Panel on Biological Hazards (BIOHAZ), et al.
Publicado: (2021) -
Transformation of Tetracycline by Manganese Peroxidase from <i>Phanerochaete chrysosporium</i>
por: Xuemei Sun, et al.
Publicado: (2021) -
Tetracycline-grafted PLGA nanoparticles as bone-targeting drug delivery system
por: Wang H, et al.
Publicado: (2015)